{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:48:25Z","timestamp":1740138505716,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s12035-023-03307-w","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T09:07:50Z","timestamp":1679994470000},"page":"3873-3882","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ganglioside-focused Glycan Array Reveals Abnormal Anti-GD1b Auto-antibody in Plasma of Preclinical Huntington\u2019s Disease"],"prefix":"10.1007","volume":"60","author":[{"given":"Tien-Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Kai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Ru","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung-Hsien","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Tai","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hung","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Lin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwai-I","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiung-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6596-6338","authenticated-orcid":false,"given":"Yun-Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"issue":"7","key":"3307_CR1","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1021\/pr0700753","volume":"6","author":"A Dalrymple","year":"2007","unstructured":"Dalrymple A, Wild EJ, Joubert R, Sathasivam K, Bjorkqvist M, Petersen A et al (2007) Proteomic profiling of plasma in Huntington\u2019s disease reveals neuroinflammatory activation and biomarker candidates. J Proteome Res 6(7):2833\u20132840. https:\/\/doi.org\/10.1021\/pr0700753","journal-title":"J Proteome Res"},{"issue":"4","key":"3307_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 4(4):398\u2013403. https:\/\/doi.org\/10.1038\/ng0893-398","journal-title":"Nat Genet"},{"issue":"7","key":"3307_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.drudis.2014.03.002","volume":"19","author":"R Andre","year":"2014","unstructured":"Andre R, Scahill RI, Haider S, Tabrizi SJ (2014) Biomarker development for Huntington\u2019s disease. Drug Discov Today 19(7):972\u2013979. https:\/\/doi.org\/10.1016\/j.drudis.2014.03.002","journal-title":"Drug Discov Today"},{"issue":"7","key":"3307_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","volume":"21","author":"SJ Tabrizi","year":"2022","unstructured":"Tabrizi SJ, Schobel S, Gantman EC, Mansbach A, Borowsky B, Konstantinova P et al (2022) A biological classification of Huntington\u2019s disease: the Integrated Staging System. Lancet Neurol 21(7):632\u2013644. https:\/\/doi.org\/10.1016\/S1474-4422(22)00120-X","journal-title":"Lancet Neurol"},{"key":"3307_CR5","doi-asserted-by":"publisher","first-page":"712555","DOI":"10.3389\/fneur.2021.712555","volume":"12","author":"KM Kinnunen","year":"2021","unstructured":"Kinnunen KM, Schwarz AJ, Turner EC, Pustina D, Gantman EC, Gordon MF et al (2021) Volumetric MRI-based biomarkers in Huntington\u2019s disease: an evidentiary review. Front Neurol 12:712555. https:\/\/doi.org\/10.3389\/fneur.2021.712555","journal-title":"Front Neurol"},{"issue":"6","key":"3307_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S1474-4422(20)30143-5","volume":"19","author":"RI Scahill","year":"2020","unstructured":"Scahill RI, Zeun P, Osborne-Crowley K, Johnson EB, Gregory S, Parker C et al (2020) Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington\u2019s disease Young Adult Study (HD-YAS): a cross-sectional analysis. Lancet Neurol 19(6):502\u2013512. https:\/\/doi.org\/10.1016\/S1474-4422(20)30143-5","journal-title":"Lancet Neurol"},{"issue":"7","key":"3307_CR7","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1002\/mds.29027","volume":"37","author":"LM Byrne","year":"2022","unstructured":"Byrne LM, Schultz JL, Rodrigues FB, van der Plas E, Langbehn D, Nopoulos PC et al (2022) Neurofilament light protein as a potential blood biomarker for Huntington\u2019s disease in children. Mov Disord 37(7):1526\u20131531. https:\/\/doi.org\/10.1002\/mds.29027","journal-title":"Mov Disord"},{"issue":"6","key":"3307_CR8","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1007\/s11064-012-0744-y","volume":"37","author":"RK Yu","year":"2012","unstructured":"Yu RK, Tsai YT, Ariga T (2012) Functional roles of gangliosides in neurodevelopment: an overview of recent advances. Neurochem Res 37(6):1230\u20131244. https:\/\/doi.org\/10.1007\/s11064-012-0744-y","journal-title":"Neurochem Res"},{"issue":"3","key":"3307_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nbd.2007.05.003","volume":"27","author":"PA Desplats","year":"2007","unstructured":"Desplats PA, Denny CA, Kass KE, Gilmartin T, Head SR, Sutcliffe JG et al (2007) Glycolipid and ganglioside metabolism imbalances in Huntington\u2019s disease. Neurobiol Dis 27(3):265\u2013277. https:\/\/doi.org\/10.1016\/j.nbd.2007.05.003","journal-title":"Neurobiol Dis"},{"key":"3307_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0079-6123(08)61938-X","volume":"101","author":"RK Yu","year":"1994","unstructured":"Yu RK (1994) Development regulation of ganglioside metabolism. Prog Brain Res 101:31\u201344","journal-title":"Prog Brain Res"},{"issue":"11","key":"3307_CR11","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1523\/JNEUROSCI.6348-09.2010","volume":"30","author":"V Maglione","year":"2010","unstructured":"Maglione V, Marchi P, Di Pardo A, Lingrell S, Horkey M, Tidmarsh E et al (2010) Impaired ganglioside metabolism in Huntington\u2019s disease and neuroprotective role of GM1. J Neurosci 30(11):4072\u20134080. https:\/\/doi.org\/10.1523\/JNEUROSCI.6348-09.2010","journal-title":"J Neurosci"},{"issue":"1","key":"3307_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ana.410240113","volume":"24","author":"A Pestronk","year":"1988","unstructured":"Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW et al (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24(1):73\u201378. https:\/\/doi.org\/10.1002\/ana.410240113","journal-title":"Ann Neurol"},{"key":"3307_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/j.1749-6632.1998.tb09684.x","volume":"845","author":"N Baumann","year":"1998","unstructured":"Baumann N, Harpin ML, Marie Y, Lemerle K, Chassande B, Bouche P et al (1998) Antiglycolipid antibodies in motor neuropathies. Ann N Y Acad Sci 845:322\u2013329","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"3307_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1002\/ana.410440621","volume":"44","author":"BT Sadatipour","year":"1998","unstructured":"Sadatipour BT, Greer JM, Pender MP (1998) Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis. Ann Neurol 44(6):980\u2013983. https:\/\/doi.org\/10.1002\/ana.410440621","journal-title":"Ann Neurol"},{"issue":"6","key":"3307_CR15","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/chem.200903035","volume":"16","author":"CH Hsu","year":"2010","unstructured":"Hsu CH, Chu KC, Lin YS, Han JL, Peng YS, Ren CT et al (2010) Highly alpha-selective sialyl phosphate donors for efficient preparation of natural sialosides. Chemistry 16(6):1754\u20131760. https:\/\/doi.org\/10.1002\/chem.200903035","journal-title":"Chemistry"},{"issue":"40","key":"3307_CR16","doi-asserted-by":"publisher","first-page":"9391","DOI":"10.1002\/anie.201101794","volume":"50","author":"KC Chu","year":"2011","unstructured":"Chu KC, Ren CT, Lu CP, Hsu CH, Sun TH, Han JL et al (2011) Efficient and stereoselective synthesis of alpha(2-->9) oligosialic acids: from monomers to dodecamers. Angew Chem Int Ed Engl 50(40):9391\u20139395. https:\/\/doi.org\/10.1002\/anie.201101794","journal-title":"Angew Chem Int Ed Engl"},{"issue":"33","key":"3307_CR17","doi-asserted-by":"publisher","first-page":"11661","DOI":"10.1073\/pnas.0804923105","volume":"105","author":"CC Wang","year":"2008","unstructured":"Wang CC, Huang YL, Ren CT, Lin CW, Hung JT, Yu JC et al (2008) Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer. Proc Natl Acad Sci U S A 105(33):11661\u201311666. https:\/\/doi.org\/10.1073\/pnas.0804923105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"3307_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1002\/ajmg.b.31232","volume":"156b","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Long JD, Mills JA, Warner JH, Lu W, Paulsen JS (2011) Indexing disease progression at study entry with individuals at-risk for Huntington disease. Am J Med Genet B Neuropsychiatr Genet 156b(7):751\u2013763. https:\/\/doi.org\/10.1002\/ajmg.b.31232","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"1","key":"3307_CR19","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1038\/s41467-019-12740-2","volume":"10","author":"HB Schmidt","year":"2019","unstructured":"Schmidt HB, Barreau A, Rohatgi R (2019) Phase separation-deficient TDP43 remains functional in splicing. Nat Commun 10(1):4890. https:\/\/doi.org\/10.1038\/s41467-019-12740-2","journal-title":"Nat Commun"},{"issue":"7","key":"3307_CR20","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1073\/pnas.1400283111","volume":"111","author":"YW Lou","year":"2014","unstructured":"Lou YW, Wang PY, Yeh SC, Chuang PK, Li ST, Wu CY et al (2014) Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers. Proc Natl Acad Sci U S A 111(7):2482\u20132487. https:\/\/doi.org\/10.1073\/pnas.1400283111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3307_CR21","doi-asserted-by":"publisher","first-page":"19509","DOI":"10.1038\/srep19509","volume":"6","author":"SM Muthana","year":"2016","unstructured":"Muthana SM, Gildersleeve JC (2016) Factors affecting anti-Glycan IgG and IgM repertoires in human serum. Sci Rep 6:19509. https:\/\/doi.org\/10.1038\/srep19509","journal-title":"Sci Rep"},{"issue":"2","key":"3307_CR22","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.expneurol.2009.09.024","volume":"223","author":"H Hampel","year":"2010","unstructured":"Hampel H, Shen Y, Walsh DM, Aisen P, Shaw LM, Zetterberg H et al (2010) Biological markers of amyloid beta-related mechanisms in Alzheimer\u2019s disease. Exp Neurol 223(2):334\u2013346. https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.024","journal-title":"Exp Neurol"},{"key":"3307_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mcn.2019.02.004","volume":"97","author":"P Zeun","year":"2019","unstructured":"Zeun P, Scahill RI, Tabrizi SJ, Wild EJ (2019) Fluid and imaging biomarkers for Huntington\u2019s disease. Mol Cell Neurosci 97:67\u201380. https:\/\/doi.org\/10.1016\/j.mcn.2019.02.004","journal-title":"Mol Cell Neurosci"},{"key":"3307_CR24","doi-asserted-by":"publisher","first-page":"541259","DOI":"10.1155\/2013\/541259","volume":"2013","author":"G Ellrichmann","year":"2013","unstructured":"Ellrichmann G, Reick C, Saft C, Linker RA (2013) The role of the immune system in Huntington\u2019s disease. Clin Dev Immunol 2013:541259. https:\/\/doi.org\/10.1155\/2013\/541259","journal-title":"Clin Dev Immunol"},{"issue":"8","key":"3307_CR25","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1084\/jem.20080178","volume":"205","author":"M Bjorkqvist","year":"2008","unstructured":"Bjorkqvist M, Wild EJ, Thiele J, Silvestroni A, Andre R, Lahiri N et al (2008) A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington\u2019s disease. J Exp Med 205(8):1869\u20131877. https:\/\/doi.org\/10.1084\/jem.20080178","journal-title":"J Exp Med"},{"issue":"2","key":"3307_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ana.25647","volume":"87","author":"MR von Essen","year":"2020","unstructured":"von Essen MR, Hellem MNN, Vinther-Jensen T, Ammitzboll C, Hansen RH, Hjermind LE et al (2020) Early intrathecal T helper 17.1 cell activity in Huntington disease. Ann Neurol 87(2):246\u2013255. https:\/\/doi.org\/10.1002\/ana.25647","journal-title":"Ann Neurol"},{"key":"3307_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1326-9-49","volume":"9","author":"DH Lee","year":"2014","unstructured":"Lee DH, Heidecke H, Schroder A, Paul F, Wachter R, Hoffmann R et al (2014) Increase of angiotensin II type 1 receptor auto-antibodies in Huntington\u2019s disease. Mol Neurodegener 9:49. https:\/\/doi.org\/10.1186\/1750-1326-9-49","journal-title":"Mol Neurodegener"},{"key":"3307_CR28","doi-asserted-by":"publisher","first-page":"175628642211097","DOI":"10.1177\/17562864221109750","volume":"15","author":"J Achenbach","year":"2022","unstructured":"Achenbach J, Saft C, Faissner S, Ellrichmann G (2022) Positive effect of immunomodulatory therapies on disease progression in Huntington\u2019s disease? Data from a real-world cohort. Ther Adv Neurol Disord 15:17562864221109750. https:\/\/doi.org\/10.1177\/17562864221109750","journal-title":"Ther Adv Neurol Disord"},{"key":"3307_CR29","doi-asserted-by":"publisher","first-page":"572965","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"S Sipione","year":"2020","unstructured":"Sipione S, Monyror J, Galleguillos D, Steinberg N, Kadam V (2020) Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci 14:572965. https:\/\/doi.org\/10.3389\/fnins.2020.572965","journal-title":"Front Neurosci"},{"issue":"1","key":"3307_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","volume":"27","author":"HC Lehmann","year":"2007","unstructured":"Lehmann HC, Lopez PH, Zhang G, Ngyuen T, Zhang J, Kieseier BC et al (2007) Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci 27(1):27\u201334. https:\/\/doi.org\/10.1523\/JNEUROSCI.4017-06.2007","journal-title":"J Neurosci"},{"issue":"12","key":"3307_CR31","doi-asserted-by":"publisher","first-page":"12253","DOI":"10.1007\/s11033-022-07830-2","volume":"49","author":"HS Hart","year":"2022","unstructured":"Hart HS, Valentin MA, Peters ST, Holler SW, Wang H, Harmon AF et al (2022) The cytoprotective role of GM1 ganglioside in Huntington disease cells. Mol Biol Rep 49(12):12253\u201312258. https:\/\/doi.org\/10.1007\/s11033-022-07830-2","journal-title":"Mol Biol Rep"},{"issue":"9","key":"3307_CR32","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1073\/pnas.1114502109","volume":"109","author":"A Di Pardo","year":"2012","unstructured":"Di Pardo A, Maglione V, Alpaugh M, Horkey M, Atwal RS, Sassone J et al (2012) Ganglioside GM1 induces phosphorylation of mutant huntingtin and restores normal motor behavior in Huntington disease mice. Proc Natl Acad Sci U S A 109(9):3528\u20133533. https:\/\/doi.org\/10.1073\/pnas.1114502109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3307_CR33","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.15252\/emmm.201707763","volume":"9","author":"M Alpaugh","year":"2017","unstructured":"Alpaugh M, Galleguillos D, Forero J, Morales LC, Lackey SW, Kar P et al (2017) Disease-modifying effects of ganglioside GM1 in Huntington\u2019s disease models. EMBO Mol Med 9(11):1537\u20131557. https:\/\/doi.org\/10.15252\/emmm.201707763","journal-title":"EMBO Mol Med"},{"key":"3307_CR34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3410\/B2-21","volume":"2","author":"KA Sheikh","year":"2010","unstructured":"Sheikh KA, Zhang G (2010) An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barre syndrome. F1000 Biol Rep 2:21. https:\/\/doi.org\/10.3410\/B2-21","journal-title":"F1000 Biol Rep"},{"issue":"1","key":"3307_CR35","doi-asserted-by":"publisher","first-page":"e28031","DOI":"10.1002\/pbc.28031","volume":"67","author":"FM Balis","year":"2020","unstructured":"Balis FM, Busch CM, Desai AV, Hibbitts E, Naranjo A, Bagatell R et al (2020) The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma. Pediatr Blood Cancer 67(1):e28031. https:\/\/doi.org\/10.1002\/pbc.28031","journal-title":"Pediatr Blood Cancer"},{"issue":"14","key":"3307_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1056\/NEJMoa0911123","volume":"363","author":"AL Yu","year":"2010","unstructured":"Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX et al (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med 363(14):1324\u20131334. https:\/\/doi.org\/10.1056\/NEJMoa0911123","journal-title":"N Engl J Med"},{"issue":"2","key":"3307_CR37","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/ana.24406","volume":"78","author":"J Drouin-Ouellet","year":"2015","unstructured":"Drouin-Ouellet J, Sawiak SJ, Cisbani G, Lagace M, Kuan WL, Saint-Pierre M et al (2015) Cerebrovascular and blood-brain barrier impairments in Huntington\u2019s disease: potential implications for its pathophysiology. Ann Neurol 78(2):160\u2013177. https:\/\/doi.org\/10.1002\/ana.24406","journal-title":"Ann Neurol"},{"key":"3307_CR38","doi-asserted-by":"publisher","first-page":"41316","DOI":"10.1038\/srep41316","volume":"7","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo A, Amico E, Scalabri F, Pepe G, Castaldo S, Elifani F et al (2017) Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington Disease. Sci Rep 7:41316. https:\/\/doi.org\/10.1038\/srep41316","journal-title":"Sci Rep"},{"issue":"6","key":"3307_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/ana.25107","volume":"82","author":"G Sciacca","year":"2017","unstructured":"Sciacca G, Cicchetti F (2017) Mutant huntingtin protein expression and blood-spinal cord barrier dysfunction in Huntington disease. Ann Neurol 82(6):981\u2013994. https:\/\/doi.org\/10.1002\/ana.25107","journal-title":"Ann Neurol"},{"issue":"1","key":"3307_CR40","doi-asserted-by":"publisher","first-page":"e15809","DOI":"10.1371\/journal.pone.0015809","volume":"6","author":"YC Huang","year":"2011","unstructured":"Huang YC, Wu YR, Tseng MY, Chen YC, Hsieh SY, Chen CM (2011) Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington\u2019s disease. PloS One 6(1):e15809. https:\/\/doi.org\/10.1371\/journal.pone.0015809","journal-title":"PloS One"},{"issue":"49","key":"3307_CR41","doi-asserted-by":"publisher","first-page":"34584","DOI":"10.1074\/jbc.274.49.34584","volume":"274","author":"H Pyo","year":"1999","unstructured":"Pyo H, Joe E, Jung S, Lee SH, Jou I (1999) Gangliosides activate cultured rat brain microglia. J Biol Chem 274(49):34584\u201334589","journal-title":"J Biol Chem"},{"issue":"Pt 7","key":"3307_CR42","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/brain\/awm044","volume":"130","author":"YF Tai","year":"2007","unstructured":"Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ et al (2007) Microglial activation in presymptomatic Huntington\u2019s disease gene carriers. Brain 130(Pt 7):1759\u20131766. https:\/\/doi.org\/10.1093\/brain\/awm044","journal-title":"Brain"},{"key":"3307_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","volume":"44","author":"KH Chang","year":"2015","unstructured":"Chang KH, Wu YR, Chen YC, Chen CM (2015) Plasma inflammatory biomarkers for Huntington\u2019s disease patients and mouse model. Brain Behav Immun 44:121\u2013127. https:\/\/doi.org\/10.1016\/j.bbi.2014.09.011","journal-title":"Brain Behav Immun"},{"key":"3307_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1756-6606-6-55","volume":"6","author":"A Di Pardo","year":"2013","unstructured":"Di Pardo A, Alberti S, Maglione V, Amico E, Cortes EP, Elifani F et al (2013) Changes of peripheral TGF-beta1 depend on monocytes-derived macrophages in Huntington disease. Mol Brain 6:55. https:\/\/doi.org\/10.1186\/1756-6606-6-55","journal-title":"Mol Brain"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03307-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03307-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03307-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T14:31:49Z","timestamp":1685197909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03307-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3307"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03307-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"16 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by IRB in Chang Gung Memorial Hospital at Linkou and Academia Sinica (IRB01-12137).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}